EUVIMEDEUVIMED entdecken
Crossref

Charge‐Regulation Activable Theranostic Probe for Tumor‐Specific Fluorescence Imaging and Chemo‐Phototherapy

Nana Su, Yanhong Lin, Bingling Zhang, Yuxiao Kang, Yuhang Li, Chang Lu, Xiaole Zhou iD, Qingqing Huang, Leyu Wang

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202505434 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Nana Su und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing, P. R. China. Hauptthemen laut MEDLINE: Theranostic Nanomedicine, Photochemotherapy, Optical Imaging, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Key Laboratory of Molecular Imaging, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activable theranostic probes offer significant potential for the precise diagnosis and therapy in cancer treatment. The core challenge in realizing this target is how to manipulate therapeutic and imaging activities by a simple yet efficient method. To address this, an exceptional “ charge regulation ” strategy to furnish an activable theranostic probe, GSH‐Cy5 is employed. The probe undergoes tumor‐specific activation via glutathione (GSH)‐triggered decationization, concurrently enhancing its anti‐cancer activity and tumor‐imaging contrast. Beyond this theranostic activity, GSH‐Cy5 also exhibits synergistic photothermal (PTT) and photodynamic (PDT) effects, which further amplify its therapeutic efficacy by inducing cell death through mitochondria‐mediated pathways. In vivo experiments demonstrated the effectiveness of GSH‐Cy5 , as it successfully enabled tumor visualization and selective therapy in tumor‐bearing mouse models. This work establishes GSH‐Cy5 as a transformative theranostic platform, while the “ charge regulation ” strategy opens new avenues for designing activable cyanine probes in precise tumor treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Theranostic NanomedicinePhotochemotherapyOptical ImagingNeoplasmsAnimalsHumansGlutathioneMiceCarbocyaninesCell Line, TumorMice, NudeFluorescent DyesFemaleMice, Inbred BALB C

Stichwörter der Autor:innen

activable chemotherapyactivable theranostic probesfluorescence imagingphotodynamic therapyphotothermal therapy

Substanzen

GlutathioneCarbocyaninesFluorescent Dyescyanine dye 5

Autor:innen und Institutionen

  • State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing, P. R. China.
  • Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, P. R. China.

ORCID-Profile: Xiaole Zhou

Förderung

  • National Natural Science Foundation of China
  • Shanghai Key Laboratory of Molecular Imaging
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Su, N., Lin, Y., Zhang, B., Kang, Y., Li, Y., Lu, C., Zhou, X., Huang, Q., & Wang, L. (2026). Charge‐Regulation Activable Theranostic Probe for Tumor‐Specific Fluorescence Imaging and Chemo‐Phototherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505434

Vancouver

Su N, Lin Y, Zhang B, Kang Y, Li Y, Lu C, et al. Charge‐Regulation Activable Theranostic Probe for Tumor‐Specific Fluorescence Imaging and Chemo‐Phototherapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505434

BibTeX
@article{Su2026,
  author = {Su, Nana and Lin, Yanhong and Zhang, Bingling and Kang, Yuxiao and Li, Yuhang and Lu, Chang and Zhou, Xiaole and Huang, Qingqing and Wang, Leyu},
  title = {Charge‐Regulation Activable Theranostic Probe for Tumor‐Specific Fluorescence Imaging and Chemo‐Phototherapy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202505434}
}
Kostenlos starten →